Gianluca Santoboni

Viterbo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et al.

Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et al.

Journal: Journal of psoriasis and psoriatic arthritis

Published: February 26, 2026

Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: a multicenter observational study from the BIRRA cohort.

Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: a multicenter observational study from the BIRRA cohort.

Journal: Frontiers in medicine

Published: February 18, 2026

Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic Arthritis.

Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic Arthritis.

Journal: Rheumatology and therapy

Published: December 22, 2025

Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World Study.

Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World Study.

Journal: Scientific reports

Published: December 14, 2025

Coverage and Drivers of Vaccinations in Patients with Autoimmune Rheumatic Diseases: An Italian Multicentric Study.

Coverage and Drivers of Vaccinations in Patients with Autoimmune Rheumatic Diseases: An Italian Multicentric Study.

Journal: Vaccines

Published: November 03, 2025

Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study.

Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study.

Journal: Rheumatology advances in practice

Published: April 27, 2025

Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study.

Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study.

Journal: Journal of psoriasis and psoriatic arthritis

Published: January 07, 2025

Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy.

Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy.

Journal: Clinical and experimental rheumatology

Published: December 27, 2018

Correlation between clinimetric approach and German US7 score in rheumatoid arthritis patients treated with tocilizumab: a pilot study.

Correlation between clinimetric approach and German US7 score in rheumatoid arthritis patients treated with tocilizumab: a pilot study.

Journal: Clinical and experimental rheumatology

Published: September 08, 2014

Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage?

Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage?

Journal: Rheumatology (Oxford, England)

Published: September 06, 2014

Beneficial cardiovascular effects of low-dose glucocorticoid therapy in inflammatory rheumatic diseases.

Beneficial cardiovascular effects of low-dose glucocorticoid therapy in inflammatory rheumatic diseases.

Journal: The Journal of rheumatology

Published: August 04, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026